SAN RAMON, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ENZO & ME PEDIATRIC CANCER FOUNDATION, founded in 2019, is a small nonprofit in the Philanthropy & Grantmaking sector that reported $231K in total revenue in fiscal year 2024. Revenue grew 13% year-over-year, indicating healthy expansion. Expenses of $279K exceeded revenue, resulting in a 21% operating deficit.
The mission of the Enzo & Me Pediatric Cancer Foundation is to fund cutting-edge pediatric cancer research to find better treatments and cures for all pediatric cancers as well as promoting the professional education of primary care pediatricians to improve early diagnosis and treatment.
Grant provided to UCSF used to fund Osteosarcoma research via researcher Betsy Young. The goal is to study the methods that cancer cells use to avoid detection by the natural immune system allowing...
Grant provided to UCSF used to fund Osteosarcoma research via researcher Betsy Young. The goal is to study the methods that cancer cells use to avoid detection by the natural immune system allowing them to metastasize to the lungs. Her research looks into these mechanisms in order to study a way to heighten the bodys awareness of these cells and destroy them.
Grant provided to Dr. Michelle Monje at Stanford University used to fund childhood brain tumor research specifically pontine gliomas such as DIPG. These cancers have little to no survival for...
Grant provided to Dr. Michelle Monje at Stanford University used to fund childhood brain tumor research specifically pontine gliomas such as DIPG. These cancers have little to no survival for children diagnosed and mortality generally occurs within 1 year. Dr. Monje is studying different mechanisms for understanding how these cancer cells work in the brain evade the immune system and what methods are best for treating them. Shes at the forefront of this research and has shows incredible promise in the field.
Grant provided to the Childrens Oncology Group used to fund multiple aspects of pediatric cancer research. This includes assistance with costs for cell banking costs of lab equipment for research and...
Grant provided to the Childrens Oncology Group used to fund multiple aspects of pediatric cancer research. This includes assistance with costs for cell banking costs of lab equipment for research and direct investment into research for solid tumors the most deadly form of pediatric cancers.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $230,800 | $204,230 | +0.1% |
| Expenses | $278,930 | $241,178 | +0.2% |
| Net Income | $-48,130 | $-36,948 | +0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Krista Keller | Director | 5.00 |
Director
|
$0 | $0 | $0 |
| Daniel Keller | Co-Director | 5.00 |
Director
|
$0 | $0 | $0 |
| Amy Lundberg | Board Member | 1.00 |
Officer
|
$0 | $0 | $0 |
| Cassandra Everson | Secretary | 1.00 |
Officer
|
$0 | $0 | $0 |
| Priya Thakkar | Board Member | 1.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $230,800 | $278,930 | $141,103 | $-48,130 |
| 2023 | $204,230 | $241,178 | $189,233 | $-36,948 |
Compare ENZO & ME PEDIATRIC CANCER FOUNDATION with other nonprofits in California and across the country.